Skip to main content
Pharmaceutical product and formulation background
Nutraceutical Division

Vitamin K2-4 (Menaquinone-4) 2000 ppm

Vitamin K2-4 (Menaquinone-4) 2000 ppm is a mid-strength MK-4 concentrate in solid and liquid form, offering flexibility for supplement manufacturers formulating mid-dose K2-4 products for bone mineralisation and cardiovascular health.

AvailableVitaminCAS 863-61-6
✓Supplement Grade
✓Vitamin supplement
✓Available

Vitamin K2-4 (Menaquinone-4) 2000 ppm is a mid-strength MK-4 concentrate in solid and liquid form, offering flexibility for supplement manufacturers formulating mid-dose K2-4 products for bone mineralisation and cardiovascular health.

Technical Overview

Vitamin K2-4 (Menaquinone-4) 2000 ppm – CAS 863-61-6

2-Methyl-3-(tetramethylhexadeca-2,6,10,14-tetraen-1-yl)naphthalene-1,4-dione

Available

CAS Number

863-61-6

Category

Vitamin

Therapeutic Class

Vitamin supplement

Description

Vitamin K2-4 (Menaquinone-4) 2000 ppm is a mid-strength MK-4 concentrate in solid and liquid form, offering flexibility for supplement manufacturers formulating mid-dose K2-4 products for bone mineralisation and cardiovascular health.

Applications

  • Bone mineralisation
  • Cardiovascular health
  • Calcium metabolism
  • Dietary supplements
  • Supplement premixes

Specifications

Concentration
2000 ppm
Form
Solid / Liquid

Handling & Supply Details

Packaging

10 Kg | 100 Kg | 1000 Kg

Product Inquiry

Disclaimer

Products offered are intended for use in dietary supplements, functional foods, and nutraceutical applications. The responsibility for ensuring compliance with local regulations and that the product does not infringe any third-party patent or intellectual property rights rests solely with the buyer.

This website uses cookies to optimize your navigation and adapt to your preferences. You can continue browsing without accepting. If you select "Accept", you accept the use of ALL cookies. You can also select cookies in "Cookie settings" and consult our Cookies Policy and Privacy Policy here.